Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

Abstract

Tumor-selective replicating viruses offer appealing advantages over conventional cancer therapy and are a promising new approach for the treatment of human cancer. The development of virotherapeutics is based on several strategies that each provides a different foundation for tumor-selective targeting and replication. Results emerging from clinical trials… (More)

Topics

Cite this paper

@article{Ries2004OncolyticVF, title={Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.}, author={Stefan J. Ries and Christian H. Brandts}, journal={Drug discovery today}, year={2004}, volume={9 17}, pages={759-68} }